Clever Culture Systems Limited has released a press release.
LBT Concludes APAS Clinical Trial Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Clever Culture Systems Limited on 6ix
Later from Clever Culture Systems
- LBT Innovations Completes U.S. Regulatory Submission
- LBT Begins Clinical Trials of APAS Technology
- LBT Receives Notice of Allowance for Third Patent
- Cochlear Executive Brent Barnes Appointed CEO of LBT
- LBT granted patent in Japan for core APAS technology
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems